Molecular mechanisms controlling endocytic downregulation of EGFR and ErbB3
Year: 2013
Type: dissertation
Abstract: ErbB proteins are a family of receptor tyrosine kinases that includes epidermal growth factor receptor (EGFR), ErbB2, ErbB3 and ErbB4. ErbB proteins govern many physiological processes during development and in an adult organism and their deregulated expression or signaling has been linked to many types of cancer. Downregulation of receptors by internalization and subsequent degradation is one of the mechanisms that regulate their activity. EGFR endocytosis is clathrin-dependent and controlled by ubiquitin ligase Cbl. ErbB protein activity can also be modulated therapeutically by tyrosine kinase inhibitors, or antibodies like for instance pertuzumab (PerjetaTM) that targets ErbB2 and inhibits its dimerization. This thesis aims at exploring molecular mechanisms regulating endocytic downregulation of ErbB proteins, how they influence each other with respect to signaling and downregulation, and how that can be experimentally modulated. Using molecular cloning, confocal microscopy and standard biochemical methods we studied endocytosis of EGFR and ErbB3 with respect to clathrin-dependence, signals for endocytosis and interactions with other ErbB family members in mammalian cells. We demonstrated that Cbl-mediated ubiquitination is important for the early steps of EGFR internalization and that ubiquitination can per se be a signal for EGFR endocytosis. We further observed that ErbB3 was endocytosed in a clathrin-dependent manner, but as opposed to EGFR, in the absence of added ligand and its kinase activity. Our data also demonstrated that overexpression of ErbB2 inhibits degradation of ErbB3 and this could be counteracted by pertuzumab that prevents ErbB2-ErbB3 dimerization. We also postulate that ErbB3, having marginal kinase activity, can form homodimers, but depends on heterodimerization for efficient signaling. Better understanding of those cellular processes provides foundation for advancement in cancer screening, diagnostics and treatment.
Author: Malgorzata Magdalena Sak
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2460667220